These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 39347991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    Bhandari J, Rout P, Sedhai YR.
    ; 2024 01. PubMed ID: 32310498
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.
    Piras R, Valoti E, Alberti M, Bresin E, Mele C, Breno M, Liguori L, Donadelli R, Rigoldi M, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2022 01; 13():1011580. PubMed ID: 36793547
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C.
    Acta Biomed; 2018 Dec 17; 89(9-S):153-157. PubMed ID: 30561409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl.
    Galvez C, Krall P, Rojas A, Oh J, Cano F.
    Pediatr Nephrol; 2023 Apr 17; 38(4):1195-1203. PubMed ID: 35969277
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
    Garnier A, Brochard K, Kwon T, Sellier-Leclerc AL, Lahoche A, Launay EA, Nobili F, Caillez M, Taque S, Harambat J, Michel-Bourdat G, Guigonis V, Fila M, Cloarec S, Djamal-Dine D, de Parscaux L, Allard L, Salomon R, Ulinski T, Frémeaux-Bacchi V, Morin C, Olivier-Abbal P, Colineaux H, Auriol F, Arnaud C, Kieffer I, Brusq C.
    J Am Soc Nephrol; 2023 Sep 01; 34(9):1561-1573. PubMed ID: 37303085
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of DEAP-HUS with eculizumab.
    Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C.
    Pediatr Nephrol; 2014 May 01; 29(5):841-51. PubMed ID: 24249282
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C, Brehon A, Mousseaux C, Luque Y, Senet P, Mariani P, Mohamadou I, Zafrani L, Frémeaux-Bacchi V, Rondeau E, Buob D, Rafat C.
    BMC Nephrol; 2020 Jul 11; 21(1):269. PubMed ID: 32652955
    [Abstract] [Full Text] [Related]

  • 18. Hemolytic uremic syndrome in children.
    Talarico V, Aloe M, Monzani A, Miniero R, Bona G.
    Minerva Pediatr; 2016 Dec 11; 68(6):441-455. PubMed ID: 27768015
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M.
    Am J Transplant; 2013 Aug 11; 13(8):2201-6. PubMed ID: 23731345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.